Tel Aviv University Professor Reports on New Treatment for Alzheimer’s at Meetings of the American Society for Microbiology.

Friends, it makes good sense. Why didn’t I put the information together myself?

What have we known about Alzheimer’s before this?
An early symptom is loss of the sense of smell.
Antibodies can treat the disease.
Some antibodies as well as many other proteins are too large to penetrate the blood/brain barrier.
Bacteriophages are viruses known to attack bacteria and not human cells.
Viruses can be genetically modified.

So why should we be surprised when Prof. Beka Solomon of Tel Aviv University either comes up with a phage that can dissolve amyloid plaque, or maybe the idea of genetically modifying one to carry something probably like the active site of an antibody which can latch onto and cause the destruction of the brain plaques of Alzheimer’s? And her approach is through the nose which is attached to nerves of the olfactory bulb of the brain where the sense of smell abides.

Brilliant!! And even better, it works!

This was done on mice. (They have all the luck!) The mice which had showed signs of Alzheimer’s regained their sense of smell, had better memory and at the end of one year of treatment, had 80% fewer amyloid plaques than the controls. (Hmm. How did they find that out? Ulps! Guess the mice weren’t so lucky after all.)

I’m about ready to get in line! And certainly would like to be at the head of a line to congratulate and thank Dr. Solomon for her awesome work.